Fundraising Fox

Beiersdorf Innovation Fund

Corporate VC

Hamburg · Seed–Growth · 6 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Beiersdorf Venture Capital backs breakthrough ideas, technologies and business models that could shape the future of the skin care industry, investing at the intersection of life sciences, AI, sustainability, and consumer technology where scientific breakthroughs meet consumer impact. It takes minority stakes of up to 20%, typically at Series A but from early to growth stage, with initial tickets of €0.5–5.0M and follow-on capacity. Beyond capital, portfolio companies gain hands-on collaboration with Beiersdorf's R&D teams, deep cosmetics category expertise across the product lifecycle, and access to 170+ markets via global brands like NIVEA, Eucerin and La Prairie.

Source: firm website, verified Aug 16, 2026.

Stage
Seed–Growth
Check
$550K – $5.5M
HQ
Hamburg, DE
Leads rounds
Follows
Instruments
Equity
Tracked investments
17

Team · 6 people

from the firm's website
Ascan Voswinckel· Head of Venture Capitalin
Dr. Gunes Bozkurt· Director of Venture Investments & Lead of Life Science Investmentsin
Chunchun Yao· Investment Principalin
Oleg Chervonnyi· Investment Principalin
Dr. Janina Zippel· Senior Scientist R&D Startup Scoutingin
Dr. Thomas Raschke· Team Lead R&D Startup Scoutingin

What they invest in

from 14 of 17 portfolio companies

Biotech ×9AI & Machine Learning ×4Healthtech ×4New Materials ×4Cleantech ×3Longevity ×3Circular Economy ×2Climate Tech ×2

HQs:Germany×2Switzerland×1France×1United Kingdom×1United States×1

Investments · 17 tracked

founders shown can be your intro path
Cellviecellvie.bio

cellvie develops Therapeutic Mitochondria Transplantation, a technique that augments or replaces failing mitochondria to restore cellular energy metabolism, with initial applications in ischemia-reperfusion injury (starting with kidney transplantation) and in mitochondria-enabled gene therapy for the genetic skin disease Epidermolysis Bullosa.

BiotechLongevityMedical Devices

Co-investorsTaiho Ventures, LLC

Deeplifedeeplife.coin𝕏

DeepLife is an AI techbio company that develops digital twin technology to simulate cellular behavior and disease mechanisms at the single-cell level.

AI & Machine LearningBiotechDeep TechParis, FR

Jean Baptiste Morlot(CTO)inJonathan Baptista(CEO)inJean-Baptiste Morlot(CTO)

Co-investorsEntrepreneur FirstKima VenturesYZR Capital

DePolydepoly.coin𝕏

DePoly develops a chemical recycling technology that converts unsorted, contaminated PET plastic waste into virgin-grade raw materials (PTA and MEG precursors) for producing new plastics without fossil fuels.

Circular EconomyCleantechNew MaterialsSion, CH

Co-investorsCrane Venture PartnersInfinity Recycling

Dermanosticdermanostic.com

Dermanostic is an online dermatology service where patients upload photos and information about a skin condition and receive a medical assessment from a dermatologist, typically within a few hours.

Digital HealthHealthtech

Co-investorsDvH VenturesEnjoyventure Management

Emeraldemerald.vc

Emerald is a venture capital investor focused on complex, science-driven technology sectors, backing entrepreneurs and companies working on innovations such as energy, data centers, and grid-related technology.

CleantechClimate TechEnergy

Evommuneevommune.comin

Evommune develops therapies targeting the underlying sources of chronic inflammatory diseases, aiming to provide underserved patient populations with more than symptomatic relief.

BiotechHealthtechPalo Alto, US

Luis Pena(Executive Officer, Director)Janice Drew(Executive Officer)David Cohen(Director)Gregory Moss(Executive Officer)Eugene Bauer(Executive Officer, Director)Francois Beaubien(Director)

Co-investorsAndera PartnersAvego BioScience CapitalB Capital GroupB4 CapitalFemHealth VenturesLongwood Fund+2 more

Macrobiologicsmacrobiologics.com

Macro Biologics designs, patents, and produces advanced biomaterials for applications in healthcare, clean food and water, and packaging.

BiotechHealthtechNew Materials

Melt&Marblemeltandmarble.comin

Melt&Marble develops fats and lipids using precision fermentation and molecular lipid design, producing ingredients with controlled fatty acid composition for food and personal care applications.

BiotechFoodTechNew Materials

Co-investorsCatalyze CapitalChalmers Ventures ABIndustrifondenLever VCNordic Foodtech VC

Ncanca.vc

NCA is a venture-client and early-stage investment firm that connects B2B startups with corporate partners to run pilots and scale validated demand.

Reventrevent.vc

Revent is a venture capital firm that partners with founders building companies focused on planetary and societal health, targeting health/care, education and finance, and sustainable consumption.

Climate TechImpact & Social Good

Reventasreventas.co.uk

ReVentas develops a dissolution-based recycling technology that dissolves, filters and recovers common post-consumer waste plastics to produce recycled polymer pellets that can replace virgin plastics across multiple industries.

Circular EconomyCleantechNew MaterialsLivingston, GB

Tom Rose(CEO)

Rubedo Life Sciencesrubedolife.comin

Rubedo Life Sciences develops therapeutics targeting aging by eliminating senescent cells to extend human healthspan.

AI & Machine LearningBiotechLongevityMedical Devices

Co-investorsCDP Venture CapitalEvolution VenturesKhosla VenturesLongeVCModi VenturesMoonstone Venture Capital+1 more

Salvalcosalvalco.com
Sbiomedicsbiomedic.com

S-Biomedic conducts R&D on microbiome-based skincare, developing products that target and rebalance the skin microbiome to support skin health.

BiotechHealthtechWellness & Fitness

Turbineturbine.ai𝕏

Turbine develops computational simulations of cells to accelerate drug discovery and development in oncology, using in silico predictions validated through wet lab experiments.

AI & Machine LearningBiotechDeep Tech

Szabolcs Nagy(Founder)in

Co-investorsAtlanticCrane Venture PartnersInteractive Venture Partners LlcAlpha EdisonFin CapitalSozo Ventures+2 more

Vincerebiovincerebio.comin𝕏

Vincere develops therapeutics for age-related diseases such as Parkinson's and kidney disease, using a computational platform that combines human genetics, cellular network models, and in-silico biology to identify drug targets like USP30 for mitochondrial repair.

AI & Machine LearningBiotechLongevity

Co-investorsBeresford VenturesPortal InnovationsquadraScope Venture Fund

YZR Capitalyzr-capital.comin

YZR Capital is a founder-led, independent investment platform focused on healthcare innovation, backing early-stage to growth-stage companies across Europe.

Munich, DE

Co-investorsPeakWave Ventures

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Beiersdorf Innovation Fund made?
Beiersdorf Innovation Fund has 17 tracked investments.
What stage does Beiersdorf Innovation Fund invest at?
Beiersdorf Innovation Fund invests at the Seed, Series A, Series B, Growth stages.
What is Beiersdorf Innovation Fund's typical check size?
Beiersdorf Innovation Fund typically writes checks of $550K – $5.5M.
What sectors does Beiersdorf Innovation Fund focus on?
Beiersdorf Innovation Fund focuses on AI & Machine Learning, Biotech, Climate Tech, Consumer, Healthtech, Impact & Social Good, Wellness & Fitness.
Where is Beiersdorf Innovation Fund located?
Beiersdorf Innovation Fund is headquartered in Hamburg, DE.
Does Beiersdorf Innovation Fund lead rounds?
Beiersdorf Innovation Fund typically participates in rounds rather than leading them.
Who does Beiersdorf Innovation Fund co-invest with?
Beiersdorf Innovation Fund most often shares deals with Crane Venture Partners, B Capital Group, Entrepreneur First, among 33 tracked co-investors.

Images

Beiersdorf Innovation Fund photo

Similar investors

Featured in lists